Systematic analytical characterization of new psychoactive substances: A case study  by Lobo Vicente, Joana et al.
Forensic Science International 265 (2016) 107–115Systematic analytical characterization of new psychoactive
substances: A case study
Joana Lobo Vicente a,*, Hubert Chassaigne a, Margaret V. Holland a, Fabiano Reniero a,
Kamil Kola´rˇ a,b, Salvatore Tirendi a, Ine Vandecasteele c, Inge Vinckier d, Claude Guillou a
a European Commission, Joint Research Centre, Institute for Health and Consumer Protection (IHCP), Chemical Assessment and Testing Unit, via E. Fermi, 2749,
TP 281, I-21020 Ispra (VA), Italy
bCzech Agriculture and Food inspection Authority, Kveˇtna´ 15, 603 00 Brno, Czech Republic
c European Commission, Joint Research Centre, Institute for Environment and Sustainability (IES), Sustainability Assessment Unit, via E. Fermi, 2749, TP 291,
I-21020 Ispra (VA), Italy
d Laboratory of Customs & Excises, Blijde Inkomststraat 20, B-3000 Leuven, Belgium
A R T I C L E I N F O
Article history:
Available online 1 February 2016
Keywords:
New psychoactive substances
Synthetic cannabinoids
Benzodiazepines
HR-MS/MS
NMR
A B S T R A C T
New psychoactive substances (NPS) are synthesized compounds that are not usually covered by
European and/or international laws. With a slight alteration in the chemical structure of existing illegal
substances registered in the European Union (EU), these NPS circumvent existing controls and are thus
referred to as ‘‘legal highs’’. They are becoming increasingly available and can easily be purchased
through both the internet and other means (smart shops). Thus, it is essential that the identiﬁcation of
NPS keeps up with this rapidly evolving market.
In this case study, the Belgian Customs authorities apprehended a parcel, originating from China,
containing two samples, declared as being ‘‘white pigments’’. For routine identiﬁcation, the Belgian
Customs Laboratory ﬁrst analysed both samples by gas-chromatography mass-spectrometry and
Fourier-Transform Infrared spectroscopy. The information obtained by these techniques is essential and
can give an indication of the chemical structure of an unknown substance but not the complete
identiﬁcation of its structure. To bridge this gap, scientiﬁc and technical support is ensured by the Joint
Research Centre (JRC) to the European Commission Directorate General for Taxation and Customs Unions
(DG TAXUD) and the Customs Laboratory European Network (CLEN) through an Administrative
Arrangement for fast recognition of NPS and identiﬁcation of unknown chemicals. The samples were sent
to the JRC for a complete characterization using advanced techniques and chemoinformatic tools.
The aim of this study was also to encourage the development of a science-based policy driven
approach on NPS.
These samples were fully characterized and identiﬁed as 5F-AMB and PX-3 using 1H and 13C nuclear
magnetic resonance (NMR), high-resolution tandem mass-spectrometry (HR-MS/MS) and Raman
spectroscopy. A chemoinformatic platform was used to manage, unify analytical data from multiple
techniques and instruments, and combine it with chemical and structural information.
 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Designer drugs are ‘‘analogues of compounds with proven
pharmacological activity manufactured by underground chemists
for sale on the street’’ [1]. New psychoactive substances are
designer drugs that intend to mimic controlled substances and are* Corresponding author. Tel.: +39 033278 6679.
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nd/4.0/).not yet covered by international laws. They pose a worrying threat
since they are emerging on the market in increasing numbers every
year. About 100 NPS were reported to the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA) in 2015 alone, a
25% increase from 2014 [2]. By slightly altering their chemical
structure these substances circumvent existing legal controls.
Often they are also referred to as ‘‘legal highs’’ since they are not
yet covered by the country’s drug laws and are thus sold as
replacements for the illegal classic drugs. NPS may also be
commercialized as ‘‘natural herbal products’’ or ‘‘research chemi-
cals’’ and therefore be legally sold on the market [2] distributed byarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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of NPS is mainly due to their ‘‘legal’’ aspect, which misleads the
buyer into thinking these drugs are not harmful. Their availability,
attractive packaging and appealing names also play a role [3].
The EMCDDA and the United Nations Ofﬁce on Drugs and Crime
(UNODC) monitor and categorize these new drugs. To this end, the
EMCDDA together with Europol, have started the European Union
Early Warning System (EWS) that currently monitors over 450 NPS
[2]. They are also responsible for preparing risk assessments on
these NPS and informing the member states of their existence so
they can take the appropriate legal measures. The European
Commission has prepared a proposal for a new Regulation on NPS
and a Directive amending Council Framework Decision 2004/757/
JHA on illicit drug trafﬁcking as part of the EU response to drugs
[4,5]. These proposals aim at strengthening the EU legal framework
regarding NPS in line with the EU Drugs Strategy 2013–2020
(2012/C401/01) from the EU Drugs Action Plan for the period of
2013–2016.
The number of NPS seizures was approximately 35,000 in 2013
[2]. Synthetic cannabinoids are amongst the most commonly
seized NPS in Europe with 8 out 10 seizures per year, followed by
cathinones [2]. They are mainly manufactured in China and India,
and purchased online via ‘‘darknets’’ (anonymous networks) [6]
without any age restriction. Recent publications have analyzed
cathinones and synthetic cannabinoids by NMR, gas-chromatog-
raphy–mass-spectrometry (GC–MS) and/or high-resolution liquid-
chromatography tandem mass-spectrometry (HR-LC–MS/MS) [7–
12]. A major challenge is the lack of analytical research information
available on these substances and the lack of reference standards
since they are new to the market and consequently not yet been
characterized [13]. Thus, there is a critical need for the analytical
characterization of these NPS to facilitate their detection in
biological matrices [14].
Drugs reach Europe through maritime, air and terrestrial
borders. Customs authorities are responsible for collecting and
safeguarding customs duties1, and controlling the ﬂow of goods
into the EU acting as the ﬁrst contact point of these NPS. The
majority of the customs laboratories are not equipped with
advanced analytical tools such as nuclear magnetic resonance
(NMR), high-resolution liquid-chromatography tandem mass-
spectrometry (HR-LC–MS/MS) and chemoinformatics tools, to
enable the identiﬁcation and characterization of the new and/or
relatively unknown NPS. The JRC, together with the CLEN has the
role of performing the analytical identiﬁcation of unknown
substances seized by Customs. Since public health laws are
country-dependent, the purpose of this research project is to
facilitate the law enforcement turn-over procedure through the
rapid identiﬁcation and analytical characterization of NPS.
The Belgian Customs authorities seized a parcel containing two
plastic bags, declared as ‘‘white pigments’’, coming from China.
One was labelled as 5F-AMB, a synthetic cannabinoid; and the
other was not labelled at all. The buyer had intended to purchase
the synthetic cannabinoid 5F-AMB and Clonazolam, a new
designer benzodiazepine. These are often used together with
other drugs to either increase the effects of the drug’s high, or to
counterbalance the adverse effects of other drugs [15]. Not
surprisingly, the number of analysed benzodizepines and synthetic
cannabinoids in the Belgian Customs Laboratory increased in 2015
when compared to 2014: in 2014 only 1 whereas in 2015 there
were 5. The number of synthetic cannabinoids analysed in 2015
was 68, up from 48 in 2014.
The aim of this study was to (a) fully characterize both samples
in order to conﬁrm their true identity using a consolidated1 A custom duty is a payment due to the revenue of a state, levied by force of law.
It is used to describe a tax on certain items purchased abroad.analytical strategy and chemoinformatics tools and (b) to
disseminate the results and encourage the development of a
science-based policy driven approach on NPS.
An earlier publication this year [10] has made available the
analytical proﬁle of 5F-AMB which we are complementing with the
FTIR and the Raman spectra. The full analytical proﬁle for the PX-3
sample is published here.
This paper presents an analytical strategy which allows the
characterization of unknown compounds, based on the scientiﬁc
experience of the JRC, in the use of advanced analytical techniques
(high-resolution and chemoinformatics tools). These approaches
have been successfully tested on samples provided by the CLEN,
through the successful identiﬁcation of approximately 100
samples between 2013 and 2015. This is further demonstrated
in this case study which was accomplished in collaboration with
the Belgian Customs Laboratory.
2. Materials and methods
2.1. Chemicals and reagents
For the NMR, HR-MS/MS and Raman analysis, the reagents were
all obtained from Sigma-Aldrich1 (Milan, Italy). The solvents were
all LC–MS Chromasolv1 grade from Fluka Analytical, purchased via
Sigma-Aldrich1. The deionised water used was taken from a Milli-
Q Puriﬁer with a Millipak140, 0.22 mm ﬁlter (18.2 mV cm, 25 8C).
These analytical techniques were performed at the JRC.
For the GC–MS analysis, reagent grade solvents (methanol and
dichloromethane) were obtained from Sigma-Aldrich1. For the
FTIR analysis, no solvents or reagents were used. These analyses
have been performed by the Belgian Customs Laboratory.
2.2. Sample preparation and instrumentation
2.2.1. GC–MS
For the GC–MS measurement, a small aliquot of each sample
(ca. 10–20 mg) was dissolved in a 50:50 mixture of methanol and
dichloromethane.
An Agilent1 G1530N Gas Chromatograph equipped with a
5973N Mass Detector (EI mode) was used for the determination of
the mass spectrum of the substances. The GC-column was a DB5-
MS (Phenyl Arylene polymer stationary phase) from Agilent J&W
(30 m, 0.250 mm, 0.25 mm) with helium as the carrier gas. An
initial oven temperature of 100 8C was set (no isothermal period),
ramping at 15 8C/min until it reached 320 8C and held for
15.33 min. The total run time was 30 min.
The injection volume was 1 mL in split mode (20:1) and the
injector temperature set at 280 8C.
2.2.2. FTIR
A Spectrum One FTIR from PerkinElmer1, equipped with an
ATR-accessory was used and no sample preparation was needed as
the powdered samples were measured as such on the ATR-unit.
The FTIR spectrum of the sample was recorded from 4000 down to
650 cm1.
2.2.3. NMR
For the acquisition of a 1H NMR spectrum a 10 mg aliquot of the
samples was mixed with 600 mL DMSO-d6, which was used as an
internal lock and chemical shift reference at 2.50 ppm.
The 1H NMR experiments were performed at 300 K on a
Bruker1 (Rheinstetten, Germany) spectrometer Avance III HD 600
(nominal proton frequency 600.13 MHz) equipped with a 5 mm
QCI cryo-probe (1H, 13C, 15N and 19F). The 1H and 13C chemical
shifts are expressed in d scale (ppm), referenced to the proton
signal of the DMSO-d6 (2.50 ppm for proton and 39.52 for
13C).
Fig. 1. Experimental design. A combination of advanced analytical techniques and
chemoinformatics tools allowed sample conﬁrmation.
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APT as well as two-dimensional 1H/1H COSY, 1H/1H TOCSY, 1H/13C
HSQC, 1H/13C HMBC and 1H/15N HMBC experiments.
2.2.4. HR-MS/MS
For the HR-MS/MS analysis, 1 mg of each sample was dissolved
in 5 mL of MeOH to obtain a 200 mg/mL solution. This was then
diluted with mobile phase (50:50 MeOH:H2O + 0.1% formic acid) to
obtain a sample concentration of 2 mg/mL for infusion.
The HR-MS/MS analyses were performed on a hybrid quadru-
pole time-of-ﬂight mass spectrometer (Q-TOF Premier, Waters1)
equipped with an electrospray ionization source (ESI). The
operating conditions of the Q-TOF mass spectrometer were as
follows: capillary voltage, 3.5 kV (+); sample cone voltage, 38 V;
extraction cone, 3.0 kV; source temperature, 80 8C; desolvation
temperature, 150 8C; cone ﬂow, 25 L/h; desolvation ﬂow, 450 L/h.
For the quadrupole and the collision cell, the parameters were as
follows: LM resolution, 5.0; HM resolution, 15.0; ion energy, 1.5 V;
cell entrance, 2.0 V; gas ﬂow 0.10 mL/min. Time-of-ﬂight (TOF)
was performed in the continuous extraction mode. In the non-
linear mode (W mode), an accelerating voltage of 9.0 kV and a
reﬂectron voltage of 2.0 kV were used for the TOF. The micro-
channel plate (MCP) value of the detector was set to 650 V. The
instrument was operated in the positive ESI mode. The TOF
analyzer was calibrated using a solution of sodium formate in the
m/z range of 50–1000. Mass spectra (MS mode) were collected over
the full m/z range with a scan time of 0.5 s and an interscan time of
0.05 s. The resolution used was 17,000 FWHM (i.e., an m/z 500 ion
peak has a width at half height of m/z 0.03) in the W mode. The HR-
MS/MS system was operated using MassLynx 4.1 software
(Waters1). Raw data ﬁles (*.RAW) were generated and converted
into *.CDF ﬁles using the Data Bridge tool (Waters1).
2.2.5. Raman
Pellets were prepared directly using the sample powder using
the KBr pellet technique.
Samples were analysed using a DXR Smart Raman instrument
from Thermo Scientiﬁc (Madison, WI, US), with a single exposure of
the charged coupled device (CCD), and controlled by the Thermo
Scientiﬁc OMNIC 9.1 Raman Software. The excitation laser, at
780 nm, operated between 150 and 3400 cm1 for all measure-
ments using a laser power of 50 mW on each sample and a full
range grating. Spectra were collected with a focused laser beam of
50 mm ‘pinhole’ diameter, spectral resolution of 5 cm1 and a
scanning time of 60 s. Calibration of the instrument was carried out
automatically using both neon and white light.
2.2.6. Chemoinformatic tools
The ACD/Spectrus Platform database was used, together with
Mass Frontier (Thermo Fisher Scientiﬁc1) for structural elucida-
tion.
With ACD/Spectrus, it is possible to conﬁrm the consistency of
proposed chemical structures with NMR experimental data (1D
and 2D) and assign experimental spectra with an identiﬁed
structure and easily build a central fully searchable repository of
the assigned NMR spectra.
Mass Frontier software predicts and returns MS fragmentation
pathways based on a set of general ionization (protonation in ESI+
mode), fragmentation, rearrangement (maximum number reac-
tion steps: 5) and resonance (electron transfer and charge
stabilization) rules. The software was used to predict fragmenta-
tion, confront experimental with theoretical data and annotate MS
and MS/MS spectral ion trees.
ACD Labs Spectrus Platform combined with the database
module allows the creation of a library of spectra from different
analytical sources, and the search and match of spectra available.3. Results and discussion
A schematic outline of the experimental design may be found in
Fig. 1.
3.1. GC–MS and FTIR
The GC–MS spectra of both samples are shown in Figs. 2 and 3,
respectively, and together with the HR-MS/MS spectra, and the
corresponding FTIR spectra can be found in Fig. 4.
For the ﬁrst substance, the GC–MS spectrum as well as the FTIR
spectrum corresponded well with the analytical data for 5F-AMB
available on the Scientiﬁc Working Group for the Analysis of Seized
Drugs (SWGDRUG) Website [16].
For the second sample however, no match with existing spectra
could be found. The GC–MS and the FTIR spectra showed
similarities with the ones of AB-CHMINACA, an indazole-based
synthetic cannabinoid, but there were also signiﬁcant differences.
By looking at the differences between the GC–MS spectrum in
Fig. 3 (with m/z 360 and 404) and that of AB-CHMINACA (with m/z
312 and 356) it could be deduced that the methylpropyl-group (2-
butanyl-group) that is present in AB-CHMINACA was replaced in
the substance under investigation by a group with an m/z that is 48
units lager than for methylpropyl.
These two techniques may be used for conﬁrmatory purposes if
the initial structure is previously known, or by spectral library
search and match.
3.2. NMR
The NMR analysis allows structural elucidation as a stand-alone
technique.
The observed NMR, 1H and 13C NMR, spectroscopic data is
presented below and the results of the correlation presented in
Fig. 5 for both samples.
The types of multiplicity and the coupling constants of the peaks
were determined automatically in ACD/Spectrus 2014 software
(Advanced Chemistry Development, Inc., Toronto, Canada), in which
Fig. 2. GC–MS and HR-MS/MS spectra for sample 5F-AMB (A).
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Fig. 3. GC–MS and HR-MS/MS spectra for sample PX3 (B).
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Fig. 4. FTIR spectrum for samples 5F-AMB (A) and PX3 (B).
Fig. 5. NMR correlation for samples 5F-AMB (A) and PX3 (B).
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structures was also performed.
3.2.1. 5F-AMB (A)
dH (DMSO-d6): 8.14 (1H, d, J = 8 Hz, atom 23), 8.04 (1H, d,
J = 8 Hz, atom 3), 7.80 (1H, d, J = 9 Hz, atom 26), 7.47 (1H, ddd, J = 8,
7, 1 Hz, atom 25), 7.29 (1H, t, J = 8 Hz, atom 24), 4.53 (2H, t, J = 7 Hz,
atom 15), 4.43–4.47 (2H, m, atom 4a, 19), 4.37 (1H, t, J = 6 Hz, atom
19), 3.66–3.74 (3H, m, atom 7), 2.22–2.31 (1H, m, atom 9), 1.93 (2H,
quin, J = 7 Hz, atom 16), 1.61–1.74 (2H, m, atom 18), 1.37 (2H, quin,
J = 8 Hz, atom 17) and 0.94–1.00 (6H, m, atom 10, 11).
dC (DMSO-d6): 172.5 (C-5), 162.4 (C-2), 141.1 (C-21), 136.7 (C-
12), 127.1 (C-25), 123.0 (C-24), 122.5 (C-22), 122.1 (C-23), 110.9 (C-
26), 84.1 (C-19), 57.7 (C-4), 52.3 (C-7), 49.1 (C-15), 40.0 (C-), 30.4 (C-
9), 29.8 (C-18), 29.4 (C-16), 22.5 (C-17), 19.5 (C-11) and 19.1 (C-10)
3.2.2. PX3 (B)
dH (DMSO-d6): 8.11 (1H, d, J = 8 Hz, atom 27), 7.89 (1H, d,
J = 8 Hz, atom 9), 7.77 (1H, d, J = 9 Hz, atom 30), 7.65 (1H, s, atom
Table 1
Raman spectroscopic data for sample 5F-AMB (A).
Position Intensity Possible functional
group
763.44 37.148 –C–halogens
779.81 63.751
882.74 22.351
908.95 32.149 –C5C–
1005.61 59.671 C–O–C esters
1136.23 26.042 C–N in aromatic
compound
1178.95 23.548
1214.77 25.593 Branched chain
in hydrocarbons
1240.12 36.770
1273.01 26.264 C–N in aromatic
amines
1324.16 33.366 –C–F in aliphatic
compounds
1361.24 51.548 Isopropyl group
1376.13 38.125 –CH3
1405.57 110.571 C–N in primary amides
1441.51 35.976 –CH2CH3
1472.66 60.965 N aromatic
1575.51 64.968 Possible N5N aliphatic
1653.89 50.390 Possible C5N
1738.41 17.001 Carbonyl group
2915.07 78.751 Aliphatic chain
2959.30 71.425 Aliphatic chain
2981.67 60.548 Aliphatic chain
3070.33 72.038 Aromatic ring–possibly
substituted
Table 2
Raman spectroscopic data for sample PX3 (B).
Position Intensity Possible functional
group
778.40 429.929 Subst. benzenes
1003.80 422.594 Carbon ring in cyclic
compound
1032.55 169.303 C–NH2
1181.14 122.289 C–C–N in amines
1235.86 195.035 C–O–C in ethers
1267.64 128.401 Alicyclic chain
1363.77 306.634 –C–N in amines
1412.96 278.267 –C–N in amides
1443.05 124.081 N5N aromatic
1476.47 218.405 –CH2 in aliphatic chain
1541.50 160.304 –C5C–
1576.02 231.569 NH2 in alkyl amide
1645.45 366.643 C5O in amides
2851.11 266.381 –CH attached to N
2938.70 316.625 –CH2 and –CH3 in
aliphatic chains
2988.05 151.952 –CH2 and –CH3 in
aliphatic chains
3067.17 315.546 C–H aromatic
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1, 3, 4, 6, 12, 28), 7.15–7.18 (1H, m, atom 5), 4.76 (1H, td, J = 8 and
5 Hz, atom 10a), 4.28–4.38 (2H, m, atom 18), 3.17 (1H, dd, J = 14
and 5 Hz, atom 14), 3.05–3.13 (1H, m, atom 14), 1.93 (1H, dtt,
J = 15, 7, 4 Hz, atom 19), 1.63–1.72 (2H, m, atom 21, 23), 1.61 (1H,
br d, J = 8 Hz, atom 22), 1.43–1.54 (2H, m, atom 20, 24), 1.11–1.21
(3H, m, atom 21, 22, 23) and 0.98–1.09 (2H, m, atom 20, 24)
dC (DMSO-d6): 173.1 (C-11), 161.7 (C-8), 141.6 (C-25), 138.1 (C-
2), 136.8 (C-15), 129.8 (C-4, 1), 128.5 (C-6, 3), 127.0 (C-29), 126.8
(C-5), 122.8 (C-28), 122.3 (C-26), 122.1 (C-27), 111.1 (C-30), 54.9
(C-18), 53.6 (C-10), 38.8 (C-19), 38.2 (C-14), 30.5 (C-24, 20), 26.3
(C-22) and 25.7 (C-21, 23)
3.3. HR-MS/MS
The MS and MS/MS data were imported to Mass Frontier
(Thermo Fisher Scientiﬁc1) for structural elucidation and frag-
mentation prediction conﬁrmation. This software allows to predict
fragmentation, confront experimental with theoretical data and
annotate MS and MS/MS spectral ion trees (Figs. 2 and 3).
The accurate mass spectrum obtained by the Q-TOF Premium
for samples A and B gave a parent ion peak at m/z 364.2071 and
405.2301, respectively, in agreement with the NMR spectroscopic
data. The monoisotopic mass of the compounds are (A) 363.1958
and (B) 404.2212. The fragmentation of the parent ions on both
compounds yields a match of 9 fragments for A, and 5 for B with a
5% peak height minimum requirement (threshold of 5% of the
highest peak). The use of HR-MS/MS allows the precise determi-
nation of the monoisotopic mass of a compound up to 4 decimal
places. Previously knowing the theoretical structure by the
techniques employed beforehand, allows conﬁrmation of the
molecule by fragmentation matching.
3.4. Raman
The combination of Raman spectroscopy with other analytical
tools is promising. It is a fast, non-destructive tool to differentiateamong very similar unknown chemicals. The use of peak table
results (Tables 1 and 2), in addition to the NMR assignments is
conﬁrmatory of the proposed structure and facilitates the
characterisation and identiﬁcation of NPS. The spectra (Fig. 6)
for both samples were acquired in the region of 3400.00–
150.00 cm1. For sample A, the absolute threshold was 14 and
the sensitivity of 35, whereas for sample B the absolute threshold
was of 81 of Raman intensity and the sensitivity of 48. The data is
presented in Table 1 (sample A) and Table 2 (sample B).
Analysis with GC–MS and FTIR is suitable for routine control as
it can be performed within a relatively short time (few minutes to
one hour) and with reasonable running costs. For relatively pure
samples, a GC–MS analysis together with a FTIR-spectrum can lead
to full identiﬁcation of the substance if both spectra give a match
with existing data. However, the MS-instruments that are used for
routine control are generally low-resolution single-MS instru-
ments and the analytical data obtained does not allow a full
conﬁrmation of the chemical structure of a new unknown
substance on its own rendering it insufﬁcient to be used as a
stand-alone technique.
The present work introduces a complete integrated analytical
strategy, together with chemoinformatics tools allowing the
complete characterization of unknown substances.
After analysis by GC–MS, FTIR, NMR, HR-MS/MS and Raman, the
samples were correctly identiﬁed as 5F-AMB, also known as 5F-
AMB-PINACA (systematic name: Methyl 2-(amino)-3-methylbu-
tanoate) [17,18] and PX-3, or APP-CHMINACA (systematic name:
N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(cyclohexylmethyl)indazole-3-
carboxamide), and not clonazolam.
The compound PX-3 is a synthetic cannabinoid developed and
patented by Pﬁzer1 with claimed binding afﬁnity for CB1.
The analytical results are the collaborative effort of the Belgian
Customs Laboratory, who performed a preliminary analysis, and of
the JRC which allowed the rapid identiﬁcation and conﬁrmation of
these two NPS. These were then reported by the Customs
Laboratory to its corresponding National Focal Point, who in its
turn sent an ofﬁcial notiﬁcation to the EMCDDA who then includes
them in the European Drug Network Database (EDND), a European
information system and database on new drugs.
For the sample 5F-AMB, the results support previous published
ﬁndings [10,16], complemented here with FTIR and Raman spectra.
For the sample PX-3, the analytical data is presented.
Fig. 6. Raman spectra for samples A and B.
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The systematic analytical approach used, together with the
chemoinformatics tools allowed us to structurally deﬁne and
successfully conﬁrm the identiﬁcation of both samples employing
different powerful and complementary analytical techniques.
The conﬁrmation of these NPS remains challenging and even
though GC-MS and FTIR are elucidative techniques, for the full
analytical conﬁrmation of completely new substances additional
techniques are required. The collaboration between the network of
European Customs laboratories and the JRC is being successfully
applied for the rapid identiﬁcation of these emerging NPS thus and
facilitated the identiﬁcation of these two samples as synthetic
cannabinoids, not one synthetic cannabinoid and one benzodiaze-
pine as ordered by the purchaser.
Synthetic cannabinoids mimic the effects of cannabis in the
endocannabinoid system but are more toxic than cannabis [19].
Benzodiazepines are anxiolytics with sedative properties that
increase the effect of the neurotransmitter gamma-amino butyricacid (GABA) at the GABAA receptor. They are often used together with
other drugs of abuse to either heighten the effects the drug’s high, or
to counterbalance the adverse effects of other drugs [15].
In this short case study concerning NPS from Belgium, we
illustrate the possible vulnerability of consumers who purchase
the NPS and who rely on the precarious trustworthiness of web
sellers. Instead of a synthetic cannabinoid and a benzodiazepine,
the purchaser was sent two synthetic cannabinoids which, if taken
together, could have led to severe intoxication.
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